12 hours and 40 minutes ago
Panel to Ponder Fate of Qnexa Weight-Loss Pill. Agreeing with an earlier advisory panel, the FDA in 2010 rejected the Qnexa weight loss pill over safety concerns. Now another panel will consider whether new safety data ...
Read More...
www.fyibehealthy.com

1 day and 1 hours ago
The future runaway success in diet pills Qnexa is in its final stages of approval from FDA. A successful combination of two pre-existing drugs phentermine and topiramate faced quite condemnation from FDA when it was first presented in the ...
Read More...
www.redpolygon.com

8 days and 22 hours ago
A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration showed promising results in a recent international trial, researcher.
Read More...
www.drugs.com

1 day and 1 hours ago
Qnexa the wonder weight loss pill. Filed under Diet & Fitness. May 18. Today, Obesity has turned out to be a gigantic health concern as it has engulfed almost one third population of American adults which adds up to almost 78 million of the ...
Read More...
www.talleyjones.com

2 days and 19 hours ago
Government advisers recommended approval on Thursday of a weight-loss drug developed by Arena Pharmaceuticals, making it likely that a new obesity treatment will reach the market this year. Enlarge This Image Lucas Jackson/Reuters ...
Read More...
stek.org

7 days and 23 hours ago
Qnexa, a new weight-loss drug, is awaiting FDA approval. Test volunteers experienced substantial weight loss, even if they had many weight-related health problems, the study found.
Read More...
blackdoctor.org

12 days and 12 hours ago
That would make Qnexa the only prescription appetite suppressant approved for long-term use available in the U.S. The only other widely marketed prescription weight loss drug, orlistat — sold by prescription as Xenical and ...
Read More...
www.fyibehealthy.com

2 days and 3 hours ago
A magic bullet for weight loss? Is the new drug Qnexa the answer? Beyond-Biology investigates the 1st drug that will be approved for weight loss since 1999.
Read More...
beyond-biology.com

4 hours and 4 minutes ago
Medical Methods in Obesity Treatment This month: QNEXA: Past, Present, and Future by Craig Primack, MD, FAAP, and Wendy Scinta, MD, MS, FAAFP, FASBP Column Editors: Craig Primack, MD, FAAP, and Wendy Scinta, ...
Read More...
bariatric.susanmleach.com

18 days and 8 hours ago
Last week, the influential healthcare information firm Close Concerns published a rather lengthy interview regarding my take on a wide range of issues related.
Read More...
www.drsharma.ca

9 days and 8 hours ago
Vivus (VVUS) is expected to receive on FDA Approval decision on QNEXA on or before July 17. 2012. Vivus (VVUS) stock is currently trading around $23 and could…
Read More...
www.stockstobuy.org

30 days and 8 hours ago
Vivus (VVUS) is currently waiting for FDA approval of the most anticipated weight-loss drug this year. Qnexa has completed Phase 3 clinical trials and received positive results. Based on the results, it is pretty clear that Qnexa ...
Read More...
seekingalpha.com

21 days and 4 hours ago
Qnexa likely to get FDA approval, but what's the hurry? » Petroff & Associates | If you took Fen Phen, please read this blog!
Read More...
www.petroffassociates.com

7 days and 22 hours ago
Wait Continues for Vivus' Qnexa-Vivus Inc. will have to wait an additional three months before the US Food and Drug Administration delivers a decision on the approvability status of its lead pipeline candidate, Qnexa.
Read More...
www.zacks.com

1 day and 5 hours ago
A Reasoned Case For Qnexa Approval. April 17, 2012 by: James Stocklasar Thomas Jr. | about: VVUS. Will VIVUS' (VVUS) Qnexa be approved in 2012? This author's opinion is "Yes" and "Likely" on the following two points: Efficacy - "Yes ...
Read More...
seekingalpha.com

8 days and 7 hours ago
On April 4, 2012, following the FDA's request, VIVUS submitted the Qnexa Risk Evaluation and Mitigation Strategy (REMS), which was considered a major amendment to the NDA. The submission consisted of proposed REMS ...
Read More...
www.drugs.com

22 hours and 5 minutes ago
Agreeing with an earlier advisory panel, the FDA in 2010 rejected the Qnexa weight loss pill over safety concerns. Now another panel will consider whether new safety data should make FDA change its mind.
Read More...
www.webmd.com

8 days and 20 hours ago
decrease Online Outlet Chanel Bags Handbags Purses Wallets Sale Free Shipping Hogan Scarpe getting to sleep handbag Karen Millen Stores to transport.
Read More...
forum.concorsipubblici.com

8 days and 2 hours ago
The latest round of FDA reviews includes a new anti-obesity drug called Qnexa, manufactured by VIVUS (VVUS). The drug was rejected by the FDA in 2010 due to health concerns. Now, almost two years later, the drug is back ...
Read More...
seekingalpha.com

2 days and 22 hours ago
The FDA is on the verge of re-approving a drug combo called Qnexa, which is effective but had been previously rejected on the basis of negative side effects. Let's take a look at how this drug works to see if it can offer us any ...
Read More...
wholehealthsource.blogspot.com

19 days and 21 hours ago
Volunteers who took Qnexa, a combination of the drugs phentermine and topiramate, experienced substantial weight loss, even if they had many weight-related health problems, the study found. The findings were reported this week during the European ...FDA advisers recommend approval of lorcaserinOrlando SentinelLorcaserin weight loss drug wins thumbs up from FDA panelBoston.comArena Soars After Weight-Loss Pill Wins Panel BackingBusinessWeekSeeking Alpha -New York Times -USA TODAYall 653 news articles »
Read More...

19 days and 21 hours ago
FDA panel backs obesity pill Qnexa: What happens next? Secret to weight loss isn't through fad diets or pills, study shows Qnexa and the FDA: Why safe diet drugs are hard to come by The panel voted 18-4 with one abstention to recommend approval of ...No, weight loss pills make me nervousNew York Daily NewsReader Consult: To Approve or Not to Approve?Wall Street Journal (blog)Obesity drugs vie for approval as FDA panel backs lorcaserinInPharmThe Atlantic -Bizcommunity.comall 52 news articles »
Read More...

19 days and 21 hours ago
The increase in net loss was primarily attributable to increased general and administrative expenses from spending on Qnexa pre-commercialization activities. VIVUS had cash, cash equivalents and available-for-sale securities (cash) of $333.4 million at ...Vivus' ED Drug Gets Green LightZacks.comNeedham & Company Reiterates a 'Buy' on Vivus (VVUS); Expect Approval of Qnexa ...StreetInsider.com (subscription)all 10 news articles »
Read More...

19 days and 21 hours ago
And to clarify what exactly the silver bullet pill is, it's the controversial weight loss drug Qnexa, which has only received preliminary approval from an FDA advisory panel - not from the FDA. While Dr. Oz says may this be the 'magic bullet' America ...Dr. Oz talks about new weight loss drugKOAT Albuquerqueall 3 news articles »
Read More...

19 days and 21 hours ago
In February, an advisory committee recommended the agency approve Vivus' drug Qnexa for weight loss. The FDA hasn't acted on it yet. The federal agency rejected Arena's lorcaserin in 2010, citing "modest weight loss" and concerns about a study that ...Mulling Arena Pharma's Future With Obesity Drug on Approval PathTheStreet.comShould Investors Worry About Arena's Offering?DailyFinanceFDA panel recommends lorcaserin for obesityTheHeart.Orgall 16 news articles »
Read More...

19 days and 21 hours ago
Another drug that has the potential to be extremely relevant is Qnexa. It, too, is currently waiting on FDA approval. However, it is fully developed and ready for the market. Qnexa will be used to treat obesity, and has the potential, if approved, ...and more »
Read More...

19 days and 21 hours ago
The company's lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response ...and more »
Read More...

19 days and 21 hours ago
The company also is awaiting an FDA decision on its proposed obesity drug Qnexa, which is expected in mid-July. Stendra is also known by the generic name avanafil. The drug falls into the same class as other erectile-dysfunction treatments on the ...Vivus Announces FDA Approval Of STENDRA(TM) (avanafil) Tablets For The ...MarketWatch (press release)FDA approves Vivus ED drug StendraBusinessWeekVivus Pill Promising Faster-Than Viagra Erection ApprovedBloombergall 205 news articles »
Read More...

19 days and 21 hours ago
Balancing the options - US authorities are to decide whether to approve the controversial drug Qnexa. Next, dieting the 'fast' way. We head to one of Germany's luxurious health resorts: the only catch, there's no food but plenty of water and exercise.
Read More...

19 days and 21 hours ago
In the world of weight loss, researchers reported that obese patients taking an experimental drug called Qnexa lost 10 percent of their body weight in a year. The pill combines two existing drugs: the weight-loss drug phentermine, and the anti-epilepsy ...
Read More...

7 days and 17 hours ago
THURSDAY, May 10 (HealthDay News) A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration showed promising results in a recent international trial, researchers report.
Read More...
news.yahoo.com

8 days and 3 hours ago
Panel voted 18-4 with one abstention to recommend approval of Arena's lorcaserin, concluding its benefits "outweigh the potential risks when used long term" in overweight and obese people
Read More...
news.search.yahoo.com

12 days and 1 hours ago
MOUNTAIN VIEW, Calif. VIVUS,Inc. , a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its financial results for the first quarter ...
Read More...
finance.yahoo.com

5 days and 0 hours ago
VIVUS Is A Viable Long Term Investment
Read More...
news.search.yahoo.com

8 days and 1 hours ago
BOSTON (MarketWatch) Shares of diet-drug developer Orexigen Therapeutics shot up 20% to $4.03 Friday in the wake of news that an advisory panel of the U.S. Food and Drug Administration has recommended approval of Arena Pharmaceuticals' diet pill lorcaserin based on new safety data. FDA regulators rejected lorcaserin, Orexigen's Contrave and Vivus Inc.'s Qnexa over a year ago, citing the need ...
Read More...
news.search.yahoo.com

18 days and 6 hours ago
KOAT medical expert Dr. Barry Ramo sat down with his good friend, Dr. Mehmet Oz, to talk about a new drug that could benefit thousands of people.
Read More...
news.search.yahoo.com

15 days and 10 hours ago
MOUNTAIN VIEW, Calif. VIVUS, Inc. today announced that Timothy Morris, chief financial officer, will present an overview of the company at three investor conferences during the month of May.
Read More...
finance.yahoo.com

8 days and 20 hours ago
SILVER SPRING, Md. For the second time in less than three months, an expert panel convened by the US Food and Drug Administration voted to recommend approval of a prescription weight loss drug that had previously been rejected because of safety concerns: Lorcaserin (Lorqess) was approved Thursday by an 18 to 4 vote with 1 abstention for its ability to help overweight people shed pounds with ...
Read More...
news.search.yahoo.com

8 days and 22 hours ago
A panel of experts on Thursday urged US regulators to approve what could be the first new anti-obesity drug on the market in more than a decade Lorcaserin, made by Arena Pharmaceuticals.
Read More...
news.yahoo.com

18 days and 10 hours ago
MOUNTAIN VIEW, Calif. VIVUS, Inc. today announced that it will report financial results for the first quarter ended March 31, 2012 after the NASDAQ Market closes on Monday, May 7, 2012.
Read More...
finance.yahoo.com

1 day and 9 hours ago
The big funding news this fortnight doesn’t come from public or private investors, it comes from taxpayers. As " The Pink Sheet" DAILY reported May 15, the Obama administration formally rolled out its national Alzheimer’s plan, which has been in the works for more than a year. Alzheimer’s and other ...
Read More...
invivoblog.blogspot.com

2 days and 14 hours ago
When last we tuned in in the ongoing drama that is the patent infringement lawsuit that Yahoo aimed at Facebook, Yahoo had a CEO ? Scott Thompson ? who was full steam ahead in pressing the controversial legal action. Now, multiple sources said, the Silicon Valley Internet giant has got a new one ? i ...
Read More...
wastebasket-crowd.blogspot.com

4 days and 13 hours ago
This shouldn't be the first time you've seen Skullcandy's Hesh headphones appear on TechCrunch, but I'll forgive you if it is. As a refresh, I reviewed the cans last week and found that it really came down to like vs. love. They're fine, but I can't necessarily justify a $60-$70 purchase. John felt ...
Read More...
kolomolo.blogspot.com

4 days and 15 hours ago
Exercise May Help Those at Higher Risk for Alzheimer's: Study MONDAY, Jan. 9 ( Healthday News) A new study finds that an active lifestyle may help protect against Alzheimer's-related brain changes in people who have a well-known genetic risk factor. This factor is the e4 allele (version) of the a ...
Read More...
womenfitness.healthincity.com

5 days and 20 hours ago
Flash Player 9 or higher is required to view the chart Click here to download Flash Player now As Pfizer’s rheumatoid arthritis pill and Arena Pharmaceuticals’ weight-loss drug got positive nods from federal advisory panels, the role of biotech companies in finding new treatments for major medical d ...
Read More...
www.forbes.com

7 days and 3 hours ago
Let’s catch up on the latest in obesity news. So much to talk about… The FDA approved the weight-loss drug Lorcaserin by Arena Pharmaceuticals with a 18-4 vote. This would be the first obesity drug on the market in a more than a decade. It was turned down in 2010 because of side effects (heart valve ...
Read More...
obesemom.com

7 days and 15 hours ago
Weight Loss Success: Ellen Olstein Committed To Change And Lost More Than 80 … d was a tireless social butterfly. See all stories on this topic » Physicians Weight Loss Centers Host Radio Show on KAAM 770 ited to help listeners realize that there is a solution, … See all stories on this topic » 5 Le ...
Read More...
obesityfact.com

7 days and 19 hours ago
New Weight-Loss Drug Qnexa Shows Promise in Trial – Drugs.com … s Weight-Loss Blogger Sues Southwest Airlines over 'Customers of … roach upon any part of the … ABA Journal Daily News Weight Loss Success: Ellen Olstein Committed To Change And Lost More Than 80 … d was a tireless social butterfly. See ...
Read More...
obesityfact.com

7 days and 22 hours ago
New Weight-Loss Drug Qnexa® Shows Promise A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration (FDA) showed promising results in a recent international trial, researchers report. Volunteers who took Qnexa®, a combination of the drugs phentermine and topiramate, ...
Read More...
pharmacymadesimple.blogspot.com

8 days and 7 hours ago
I was riveted by an article in today’s New York Times about the latest decision of an FDA drug advisory panel. The panel voted to approve a new weight-loss drug, lorcaserin. The vote was mixed: 18 for approval, 4 against, and 1 abstention. The majority felt that the benefits outweighed the risks and ...
Read More...
www.foodpolitics.com